Thiochromene derivatives as HIF hydroxylase inhibitors
US8927591B2 · kind B2 · utility
9Cited by
42References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2009 |
| Grant date | Jan 6, 2015 |
| Priority date | — |
| Expiry date | Sep 24, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.